12 segments · 38 companies
Medtech, Diagnostics & Care
+4.6%chain · 1M
Instruments, devices and testing support care; procedure volume and payment shape demand, with research tools on a separate branch.
- The Medtech, Diagnostics & Care covers 12 segments and 38 companies, 0 of them chokepoints.
- Over the past month the chain's median listed company returned +4.6%, against 0.0% for the S&P 500.
- The strongest segment is Research & clinical outsourcing (+11.7%) and the weakest Chronic care & home monitoring (−0.7%), a 12.4-point spread.
The chain, stage by stage
Upstream on the left, end demand on the right. Figures are 1-month returns; the segment shows its median.
Research & testingClinical devices
Tools & research
Devices, supplies & tests
Chronic care & home monitoring−0.7%
Imaging & patient monitoring+4.1%
GEHC+4.1%
Care delivery
Medical & dental distribution−2.8%
Which segments are leading
Median price return of the listed companies in each segment.
Key numbers
2024 US national health spending$5.3TCMS · National Health Expenditure fact sheet
Sources
- FDA · Medical Devices 2026-10-07(查阅)
- CMS · National Health Expenditure fact sheet 2024
Follow this chain every day
Hub links every company to its suppliers and customers, with news and alerts as the chain moves.